SCHEMBL6155089

SCHEMBL6155089

Oc1cccc(Nc2nnc(-c3cc(OCc4ccccc4)cc(OCc4ccccc4)c3)s2)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3CD O00329 1/20 0.48
PIK3CA P42336 1/20 0.48
PIK3CB P42338 1/20 0.48
GAA P10253 2/20 0.45
MGAM O43451 1/20 0.45
SI P14410 1/20 0.45
MGAM2 Q2M2H8 1/20 0.45
NOX1 Q9Y5S8 1/20 0.44
ALOX5 P09917 1/20 0.44
SIRT2 Q8IXJ6 1/20 0.42
SYK P43405 1/20 0.42
ROCK2 O75116 1/20 0.42
ROCK1 Q13464 1/20 0.42
KMT2A Q03164 4/20 0.42
CTSV O60911 1/20 0.41
CTSL P07711 1/20 0.41
CYP3A4 P08684 1/20 0.41
TSHR P16473 1/20 0.41
MEN1 O00255 3/20 0.41
RAB9A P51151 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6154251 0.87 NR1H4 (0.54) NOX1ROCK2ROCK1KMT2ACTSV
SCHEMBL6154349 0.83 GUSB (0.60) PIK3CDPIK3CAPIK3CBGAAMGAM
SCHEMBL5552894 0.82 HDAC6 (0.55) PIK3CDPIK3CAPIK3CBNOX1KMT2A
SCHEMBL6154992 0.81 FFAR1 (0.46) PIK3CDPIK3CAPIK3CBGAANOX1
SCHEMBL6677986 0.81 PIK3CD (0.41) PIK3CDPIK3CAPIK3CBGAAMGAM
SCHEMBL6155082 0.81 PIK3CD (0.41) PIK3CDPIK3CAPIK3CBGAAMGAM
SCHEMBL5557794 0.80 HDAC6 (0.52) PIK3CDPIK3CAPIK3CBNOX1SYK
SCHEMBL6153663 0.79 PDE4A (0.43) PIK3CDPIK3CAPIK3CBGAANOX1
SCHEMBL6162257 0.79 PIK3CD (0.40) PIK3CDPIK3CAPIK3CBGAAMGAM
SCHEMBL6682432 0.79 RAB9A (0.53) KMT2AMEN1RAB9ANPC1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050065118-A1 Organosulfur inhibitors of tyrosine phosphatases METABASIS THERAPEUTICS, INC. 2005-03-24 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050065118-A1 Organosulfur inhibitors of tyrosine phosphatases PTPRS, PTPRJ, PTPRCAP PIK3CD 2104/4885PIK3CA 2270/4885PIK3CB 1188/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.